Correction of male hypogonadism caused by anabolic steroid use
Open Access
- 26 April 2026
- journal article
- Published by Endocrinology Research Centre in Bulletin of Reproductive Health
- No. 1,p. 18-25
Abstract
The widespread use of anabolic steroids (AS) in sports and recreational fitness has led to an increase in the frequency of iatrogenic hypogonadotropic hypogonadism among men. This condition, characterized by the suppression of the hypothalamic-pituitary-gonadal (HPG) axis via negative feedback, manifests as severe testosterone deficiency, impaired spermatogenesis, and a wide range of negative clinical symptoms. This review systematizes current data on the methods for correcting AAS induced hypogonadism. Unlike similar works, the emphasis is placed on the pathogenetic rationale for choosing a therapeutic strategy based on clearly defined clinical goals: rapid relief of symptoms versus restoration of fertility. It provides a detailed analysis not only of classical testosterone replacement therapy but also of methods aimed at restoring endogenous steroidogenesis and spermatogenesis: therapy with gonadotropins and selective estrogen receptor modulators. Particular attention is paid to prognostic factors for treatment success, including the duration and nature of prior AAS use. Based on the analyzed data, a systematic approach to patient management is proposed, emphasizing the need for treatment individualization. The review also contains a assessment of the potential role of selective androgen receptor modulators (SARM) and an analysis of the likelihood of spontaneous recovery of HPG axis function.Keywords
This publication has 31 references indexed in Scilit:
- Selective Androgen Receptor Modulators: Current Knowledge and Clinical ApplicationsSexual Medicine Reviews, 2019
- Development of selective androgen receptor modulators (SARMs)Molecular and Cellular Endocrinology, 2018
- Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-AnalysisSports Medicine, 2017
- Male central hypogonadism secondary to exogenous androgens: a review of the drugs and protocols highlighted by the online community of users for prevention and/or mitigation of adverse effectsClinical Endocrinology, 2014
- Anabolic steroid–induced hypogonadism: diagnosis and treatmentFertility and Sterility, 2014
- Persistent primary hypogonadism associated with anabolic steroid abuseFertility and Sterility, 2011
- The Safety, Pharmacokinetics, and Effects of LGD-4033, a Novel Nonsteroidal Oral, Selective Androgen Receptor Modulator, in Healthy Young MenThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2010
- Selective androgen receptor modulators as function promoting therapiesCurrent Opinion in Clinical Nutrition and Metabolic Care, 2009
- Long-term psychiatric and medical consequences of anabolic–androgenic steroid abuse: A looming public health concern?Drug and Alcohol Dependence, 2008
- Successful treatment of anabolic steroid–induced azoospermia with human chorionic gonadotropin and human menopausal gonadotropinFertility and Sterility, 2003